Managed Account Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Managed Account Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$15.6M	Sell	368,826 -85,648	-19%	-$3.61M	0.01%	849
2015 Q1	$17.6M	Sell	454,474 -418,006	-48%	-$16.1M	0.02%	774
2014 Q4	$29.4M	Buy	872,480 +160,058	+22%	+$5.65M	0.03%	545
2014 Q3	$24.9M	Buy	712,422 +262,448	+58%	+$9M	0.03%	599
2014 Q2	$14.8M	Buy	449,974 +104,142	+30%	+$3.56M	0.02%	821
2014 Q1	$12.7M	Buy	345,832 +35,674	+12%	+$1.31M	0.02%	856
2013 Q4	$11.9M	Buy	310,158 +202,526	+188%	+$6.39M	0.02%	880
2013 Q3	$2.95M	Sell	107,632 -7,990	-7%	-$189K	﹤0.01%	1506
2013 Q2	$2.43M	Buy	+115,622	New	+$2.26M	﹤0.01%	1546

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Managed Account Advisors's WX Position: Q2 2015 in Review

Managed Account Advisors reduced its WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) stake by 19% in Q2 2015, selling an estimated $3.61M and leaving 368,826 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #849.

Managed Account Advisors first reported a position in WX in Q2 2013 and has held it in 9 quarters since. The position peaked at $29.4M in Q4 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Managed Account Advisors held 368,826 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $15.6M as of Q2 2015.
Managed Account Advisors sold 85,648 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $3.61M.
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #849 holding.
Managed Account Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $29.4M in Q4 2014.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.